CLU and hepatocellular carcinoma: Furthermore, serum clusterin levels were above the cut-off value in 5 of 12 HCCs (41.7%) in whom both serum AFP and PIVKA-II were within their cut-off values, suggesting that clusterin is complementary to the conventional two representative HCC tumor markers.